Replimune Group
REPL
140 hedge funds and large institutions have $594M invested in Replimune Group in 2023 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 52 increasing their positions, 32 reducing their positions, and 30 closing their positions.
63% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 32
43% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 30
23.05% more ownership
Funds ownership: 96.29% → 119.34% (+23%)
10% more funds holding
Funds holding: 127 → 140 (+13)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
39% less capital invested
Capital invested by funds: $971M → $594M (-$377M)
53% less call options, than puts
Call options by funds: $1.71M | Put options by funds: $3.67M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$97.7M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
+$57.6M |
| 3 |
State Street
Boston,
Massachusetts
|
+$31.8M |
| 4 |
DM
Deerfield Management
New York
|
+$21M |
| 5 |
Goldman Sachs
New York
|
+$19.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$36.7M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$24.9M |
| 3 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$22.1M |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$12.4M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$11.6M |
REPL Hedge Fund Activity: Q4 2023 in Review
140 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Replimune Group (REPL) for Q4 2023, worth a combined $594M — down 39% from $971M a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new REPL positions and 30 closed out — a net gain of 13 holders — while 52 added to existing stakes and 32 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $97.7M. The largest seller was BVF Inc, exiting entirely with an estimated $36.7M sold.
- 140 institutional investors held Replimune Group (REPL) as of Q4 2023, up from 127 in Q3 2023.
- Funds reported $594M of Replimune Group stock for Q4 2023, down 39% quarter-over-quarter.
- 43 funds opened new Replimune Group positions in Q4 2023 and 30 closed out, a net change of +13 holders.
- The largest Replimune Group buyer in Q4 2023 was Morgan Stanley, an estimated $97.7M added.
- The largest Replimune Group seller in Q4 2023 was BVF Inc, an estimated $36.7M sold.
Based on aggregated 13F filings for Q4 2023.